HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice

Seminars in Diagnostic Pathology

Volumn 32, Issue 5, 2015, Pages 344-351

  Bishop, Justin A ^a   Lewis, James S ^b   Rocco, James W ^c,d,e   Faquin, William C ^c,d,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Head and neck; HPV; Human papillomavirus; In situ hybridization; Non keratinizing squamous cell carcinoma; P16

Indexed keywords

PROTEIN P16; VIRUS RNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER; VIRUS DNA;

ARTICLE; FINE NEEDLE ASPIRATION BIOPSY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MEDICAL PRACTICE; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ANALYSIS; CARCINOMA, SQUAMOUS CELL; CHEMISTRY; GENETICS; HEAD AND NECK NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PREDICTIVE VALUE; VIROLOGY;

BIOMARKERS, TUMOR; BIOPSY, FINE-NEEDLE; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS;

EID: 84940450597     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2015.02.013     Document Type: Article

References (60)

1. D'Souza G., Kreimer A.R., Viscidi R., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007, 356:1944-1956.
2. Gillison M.L., Koch W.M., Capone R.B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92:709-720.
3. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011, 29:4294-4301.
4. Adelstein D.J., Ridge J.A., Gillison M.L., et al. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, DC. Head Neck 2009, 31:1393-1422.
5. Marur S., D'Souza G., Westra W.H., Forastiere A.A. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010, 11:781-789.
6. Ang K.K., Harris J., Wheeler R., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010, 363:24-35.
7. Ragin C.C., Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007, 121:1813-1820.
8. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008, 100:261-269.
9. Bonilla-Velez J., Mroz E.A., Hammon R.J., Rocco J.W. Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment. Otolaryngol Clin North Am 2013, 46:521-543.
10. Mirghani H., Amen F., Blanchard P., et al. Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives. Int J Cancer 2015, 136:1494-1503.
11. Westra W.H. Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol 2014, 50:771-779.
12. Begum S., Gillison M.L., Ansari-Lari M.A., Shah K., Westra W.H. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003, 9:6469-6475.
13. Bishop J.A., Ogawa T., Chang X., et al. HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Am J Surg Pathol 2012, 36:142-148.
14. Zhao M., Rosenbaum E., Carvalho A.L., et al. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer 2005, 117:605-610.
15. Chuang A.Y., Chuang T.C., Chang S., et al. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol 2008, 44:915-919.
16. Min K.W., Houck J.R. Protocol for the examination of specimens from patients with carcinomas of the upper aerodigestive tract: carcinomas of the oral cavity inluding lip and tongue, nasal and paranasal sinuses, pharynx, larynx, salivary glands, hypopharynx, oropharynx, and nasopharynx. Cancer Committee, College of American Pathologists. Arch Pathol Lab Med 1998, 122:222-230.
17. Thavaraj S., Stokes A., Mazuno K., Henley-Smith R., Suh Y.E., Paleri V., Tavassoli M., Odell E., Robinson M. Patients with HPV-related tonsil squamous cell carcinoma rarely harbour oncocgenic HPV infection at other pharyngeal sites. Oral Oncol 2014, 50:241-246.
18. Witt B.L., Albertson D.J., Coppin M.G., Horrocks C.F., Post M., Gulbahce H.E. Use of in situ hybridization for HPV in head and neck tumors: experience from a National Reference Laboratory. Head Neck Pathol 2014, [Epub ahead of print].
19. Maniakas A., Moubayed S.P., Ayad T., et al. North-American survey on HPV-DNA and p16 testing for head and neck squamous cell carcinoma. Oral Oncol 2014, 50:942-946.
20. Shoushtari A.N., Rahimi N.P., Schlesinger D.J., Read P.W. Survey on human papillomavirus/p16 screening use in oropharyngeal carcinoma patients in the United States. Cancer 2010, 116:514-519.
21. Begum S., Cao D., Gillison M., Zahurak M., Westra W.H. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005, 11:5694-5699.
22. Singhi A.D., Westra W.H. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010, 116:2166-2173.
23. Lewis J.S., Ukpo O.C., Ma X.J., et al. Transcriptionally-active high-risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas-a tissue microarray study utilizing E6/E7 mRNA in situ hybridization. Histopathology 2012, 60:982-991.
24. Poling J.S., Ma X.J., Bui S., et al. Human papillomavirus (HPV) status of non-tobacco related squamous cell carcinomas of the lateral tongue. Oral Oncol 2014, 50:306-310.
25. Bishop J.A., Ma X.J., Wang H., et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol 2012, 36:1874-1882.
26. Chernock R.D., Wang X., Gao G., et al. Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx. Mod Pathol 2013, 26:223-231.
27. Bishop J.A., Guo T.W., Smith D.F., et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol 2013, 37:185-192.
28. El-Mofty S.K., Lu D.W. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 2005, 29:1367-1372.
29. Lewis J.S., Westra W.H., Thompson L.D., et al. The sinonasal tract: another potential "Hot Spot" for carcinomas with transcriptionally-active human papillomavirus. Head Neck Pathol 2014, 8:241-249.
30. Robinson M., Suh Y.E., Paleri V., et al. Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population. Infect Agents Cancer 2013, 8:30.
31. Westra W.H. The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management. Head Neck Pathol 2012, 6(suppl 1):S48-S54.
32. Lewis J.S., Khan R.A., Masand R.P., et al. Recognition of nonkeratinizing morphology in oropharyngeal squamous cell carcinoma-a prospective cohort and interobserver variability study. Histopathology 2012, 60:427-436.
33. Chernock R.D., El-Mofty S.K., Thorstad W.L., Parvin C.A., Lewis J.S. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol 2009, 3:186-194.
34. Mehrad M., Zhao H., Gao G., Wang X., Lewis J.S. Transcriptionally-active human papillomavirus is consistently retained in the distant metastases of primary oropharyngeal squamous cell carcinomas. Head Neck Pathol 2014, 8(2):157-163.
35. Weinberger P.M., Yu Z., Haffty B.G., et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006, 24:736-747.
36. Smeets S.J., Hesselink A.T., Speel E.J., et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007, 121:2465-2472.
37. Leemans C.R., Braakhuis B.J., Brakenhoff R.H. The molecular biology of head and neck cancer. Nat Rev Cancer 2011, 11:9-22.
38. van Houten V.M., Snijders P.J., van den Brekel M.W., et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001, 93:232-235.
39. Ukpo O.C., Flanagan J.J., Ma X.J., Luo Y., Thorstad W.L., Lewis J.S. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol 2011, 35:1343-1350.
40. Schache A.G., Liloglou T., Risk J.M., et al. Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma. Br J Cancer 2013, 108:1332-1339.
41. Reed A.L., Califano J., Cairns P., et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996, 56:3630-3633.
42. Mroz E.A., Baird A.H., Michaud W.A., Rocco J.W. COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells. Cancer Res 2008, 68:6049-6053.
43. Jordan R.C., Lingen M.W., Perez-Ordonez B., et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol 2012, 36:945-954.
44. Munger K., Baldwin A., Edwards K.M., et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol 2004, 78:11451-11460.
45. Schache A.G., Liloglou T., Risk J.M., et al. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res 2011, 17:6262-6271.
46. Lewis J.S., Thorstad W.L., Chernock R.D., et al. p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol 2010, 34:1088-1096.
47. Lewis J.S., Chernock R.D., Ma X.J., et al. Partial p16 staining in oropharyngeal squamous cell carcinoma-extent and pattern correlate with human papillomavirus status. Mod Pathol 2012, 25(9):1212-1220.
48. Lingen M.W., Xiao W., Schmitt A., et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol 2013, 49:1-8.
49. Cao D., Begum S., Ali S.Z., Westra W.H. Expression of p16 in benign and malignant cystic squamous lesions of the neck. Hum Pathol 2010, 41:535-539.
50. Thavaraj S., Stokes A., Guerra E., et al. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol 2011, 64:308-312.
51. Goldenberg D., Begum S., Westra W.H., et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008, 30:898-903.
52. Begum S., Gillison M.L., Nicol T.L., Westra W.H. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 2007, 13:1186-1191.
53. Holmes B.J., Westra W.H. The expanding role of cytopathology in the diagnosis of HPV-related squamous cell carcinoma of the head and neck. Diagn Cytopathol 2014, 42:85-93.
54. Bishop J.A., Maleki Z., Valsamakis A., et al. Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: a convenient liquid-phase approach for the reliable determination of human papillomavirus status. Cancer Cytopathol 2012, 120:18-25.
55. Chute D.J., Aramouni G., Brainard J., Hoschar A., Kroger A., Yen-Lieberman B. Hybrid capture 2 human papilloma virus testing for head and neck cytology specimens. J Am Soc Cytopathol 2014, 3:173-182.
56. Smith D.F., Maleki Z., Coughlan D., et al. Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay. Oral Oncol 2014, 50:600-604.
57. Guo M., Khanna A., Dhillon J., et al. Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma. Cancer Cytopathol 2014, 122:96-103.
58. Solomides C.C., Bibbo M., Wang Z.X. Assessment of fine needle aspiration specimen adequacy for high-risk HPV detection and genotyping in oropharyngeal squamous cell carcinoma. Acta Cytol 2012, 56:196-198.
59. Faquin W.C. Human papilloma virus assays for testing fine-needle aspiration specimens in patients with head and neck squamous cell carcinoma. Cancer Cytopathology 2014, 122:92-95.
60. Kerr D.A., Pitman M.B., Sweeney B., Arpin R.N., Wilbur D.C., Faquin W.C. Performance of the Roche cobas 4800 high risk HPV test in cytologic preparations of squamous cell carcinoma of the head and neck. Cancer Cytopathol 2014, 122:167-174.